Navigation Links
RNL BIO filed Phase II/III Clinical Trial with KFDA to Treat Cerebral Palsy Using Autologous Fat Derived Stem Cells
Date:2/8/2013

r 1000 male to 2.8 per 1000 female children, averaged at 3.2 per 1000 children, which is expected to increase due to reduction of premature death.

In the clinical study investigators employ a variety of methods to assess efficacy: K-ABC: Kaufman Assessment Battery for Children, Gross Motor Function Measure, (GMFM), box and block test, Modified Asworth Scale, MAS, finger tapping test, Brain SPECT and MRI.

Dr. JC Ra, president of RNL BIO Stem Cell Technology Institute, said, "It is our mission to find cures for incurable diseases, such as the terrible pediatric curse of cerebral palsy, through autologous stem cell technology." 

About RNL BIO

RNL BIO is a premier biotechnology company focused on the research and development of adult derived stem cell technologies. RNL has completed one phase I trial for spinal cord injury and one Phase II clinical trial for Osteoarthritis and is near to the completion of Buerger's Disease trial. RNL has been a supporter of UN Global Compact's free program to work with children who suffer from cerebral palsy, as major sponsor of the Bethesda Life Foundation. RNL is a publicly traded company on the Korean Stock Exchange (Code 003190) and is expanding its operations throughout the world.


'/>"/>
SOURCE RNL BIO
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Faruqi & Faruqi, LLP Notifies Investors of June 4, 2012 Lead Plaintiff Deadline for the Class Action Filed Against Chelsea Therapeutics International
2. Sosei Group Corporation: QVA149 Filed as a Once-Daily Maintenance Treatment for COPD in Europe
3. Sosei Group Corporation: QVA149 Filed by Licensing Partner as a Once-Daily Maintenance Treatment for COPD in Japan
4. Bernstein Liebhard LLP Announces That A Class Action Has Been Filed Against Abiomed, Inc.
5. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
6. Lotus Pharmaceutical Company Inc. Filed Its Abbreviated New Drug Application (ANDA) Containing a Paragraph IV Certification for a Generic Version of Xenical(R) with the U.S. Food & Drug Administration (FDA)
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
10. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
11. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2
... to the American Diabetes Association, total costs of diagnosed ... at $174 billion.  Millions of Americans have been diagnosed ... that they are at risk or in fact living ... pills to manage their diabetes and these medications can ...
... Mass., Nov. 1, 2010 Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... dedicated to serving the healthcare needs of women, ... American Society of Breast Surgeons (ASBS) MammoSite® Breast ...
Cached Medicine Technology:Stater Bros. Super Rx Pharmacy Offers FREE Diabetic Medications 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 2Hologic Announces Long-term, Five-year Results from MammoSite® ASBS Registry Study 3
(Date:4/18/2014)... new article published online in The Gerontologist ... religious music is associated with a decrease in anxiety ... sense of control over their lives. In particular, listening ... anxiety about death and an increase in sense of ... whites, women and men, and individuals of both low- ...
(Date:4/18/2014)... Benaroya Research Institute at Virginia Mason (BRI) recently received ... in metastatic breast cancer reduces both the growth of ... scientists have found in models of the disease that ... 80 percent and can keep the tumor from metastasizing ... grant comes from the National Cancer Institute of the ...
(Date:4/18/2014)... scientists could lead to potential new treatments for breaking ... , Fibrosis, or scarring, is a hallmark of ... lungs can lead to serious organ damage and, in ... options centers on findings made by Swati Bhattacharyya, PhD, ... that a specific protein plays in promoting fibrosis. ...
(Date:4/17/2014)... have identified new pain relief targets that could ... BBSRC-funded researchers at King,s College London made the ... in the periphery of the body. , Dr ... identifying mechanisms underlying pain generation and our findings ... side effects." , One potential side effect of ...
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:New clues on tissue scarring in scleroderma 2Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2
... Nonviolent Peaceforce (NP) is pleased to share today the release ... Basilan Island in the Mindanao region of the Philippines who was ... on Friday, Feb. 13. Jaleel is alive and is currently ... 1245 UTC near the vicinity of Tipo Tipo on Basilan. ...
... ... program for Biopolymers Symposium 2009 taking place September 28 - 30th in Chicago, IL ... ... IntertechPira is pleased to announce the Biopolymers Symposium 2009 conference and exhibit, taking place ...
... Camacho, Shirley Flores-Munoz and Tomas A. Magana awarded $25,000 each ... , LOS ANGELES, June 3 Guillermo J. Camacho, ... give back to a program at California State Polytechnic University, ... Shirley Flores-Munoz of Watsonville founded and directs a program ...
... the best gift-giving strategy if you,re a woman trying to figure out ... do - give him the gift you really want for yourself. , ... , , OK, that probably rules out the ,65 Mustang and ... be the best present for millions of women - one that would ...
... confirmation of bile duct, pancreatic cancers, , WEDNESDAY, June 3 ... new tests that make it easier to diagnose cancers of ... new tests more than doubled the detection rate of these ... discovered until their later stages. , "The earlier we can ...
... chooses Cincom Eloquence to streamline policy generation , ... Systems announces that Medica ( www.medica.com ), ... 1.5 million members, has chosen Cincom Eloquence(R) ( ... , , Key considerations for Medica,s selection of ...
Cached Medicine News:Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 2Health News:Kidnapped Nonviolent Peaceforce Civilian Peacekeeper Released Unharmed 3Health News:Biopolymers Symposium 2009 Announces Final Program and Interactive Green Brochure 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 2Health News:Mentors Who Support Students Receive TCWF Champions of Health Professions Diversity Award 3Health News:Perfect Father's Day Gift: The Sound of Silence 2Health News:Perfect Father's Day Gift: The Sound of Silence 3Health News:New Tests Spot Tough-to-Detect Cancers Sooner 2Health News:Medica Selects Cincom's Document Automation Software 2Health News:Medica Selects Cincom's Document Automation Software 3
HemoSite meter can be used to measure the effects of transfusion or the treatment of deficiency states. It is fast, easy, convenient and discrete....
... The Hgb Pro Professional Hemoglobin Testing System ... single-use test strips, used in measuring total ... The Hgb Pro provides the precision, accuracy ... ,The Hgb Pro Professional Hemoglobin Testing System ...
... D-10 Hemoglobin Testing System: The ... in a small package. It provides a ... and B-thalassemia testing into a single platform. ... only a touch screen away and can ...
... hemoglobin testing system (110V) ... for diabetes monitoring, sickle ... hemoglobinopathy screening and multiple ... test. It has bar ...
Medicine Products: